Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2025-12-25 @ 4:09 AM
NCT ID:
NCT04447820
Eligibility Criteria:
Inclusion Criteria:
* Able to provide written informed consent before any study-specific evaluation is performed
* At screening, have a mean fasting TG level of ≥180 mg/dL and \<550 mg/dL; at subsequent Qualification Period visits confirm fasting TG level of ≥200 mg/dL and \<500 mg/dL
* Able to meet all inclusion criteria outlined in clinical study protocol
Exclusion Criteria:
* Require lipid-altering treatments other than study drugs, statins, ezetimibe, or PCSK9 inhibitors during the study
* Known hypersensitivity or intolerance to fibrates or peroxisome proliferator-activated receptor alpha agonists
* Meet any other exclusion criteria outlined in clinical study protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04447820
Study Brief:
Protocol Section:
NCT04447820